Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−23.993 CAD
−34.84 M CAD
0.00 CAD
1.94 M
About Aptose Biosciences. Inc.
Sector
Industry
CEO
William G. Rice
Website
Headquarters
Toronto
Founded
1986
ISIN
CA03835T4081
FIGI
BBG00JVRKXM5
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0UI8 is 5.160 CAD — it has decreased by −97.75% in the past 24 hours. Watch Aptose Biosciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Aptose Biosciences Inc. stocks are traded under the ticker 0UI8.
0UI8 reached its all-time high on Mar 24, 2021 with the price of 1,502,550.020 CAD, and its all-time low was 5.160 CAD and was reached on Mar 24, 2025. View more price dynamics on 0UI8 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0UI8 stock is 4.35 K% volatile and has beta coefficient of −2.48. Track Aptose Biosciences Inc. stock price on the chart and check out the list of the most volatile stocks — is Aptose Biosciences Inc. there?
Today Aptose Biosciences Inc. has the market capitalization of 4.08 M, it has increased by 12.26% over the last week.
Yes, you can track Aptose Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
Aptose Biosciences Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
0UI8 earnings for the last quarter are −3.76 CAD per share, whereas the estimation was −3.73 CAD resulting in a −0.73% surprise. The estimated earnings for the next quarter are −2.72 CAD per share. See more details about Aptose Biosciences Inc. earnings.
0UI8 net income for the last quarter is −9.75 M CAD, while the quarter before that showed −7.95 M CAD of net income which accounts for −22.55% change. Track more Aptose Biosciences Inc. financial stats to get the full picture.
No, 0UI8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 3, 2025, the company has 13 employees. See our rating of the largest employees — is Aptose Biosciences Inc. on this list?
Like other stocks, 0UI8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptose Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptose Biosciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptose Biosciences Inc. stock shows the sell signal. See more of Aptose Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.